454 Life Sciences, part of Roche, and researchers at Columbia University identified a virus associated with the deaths of 2.4 million honey bee colonies.
Branford, CT (Sept. 6)-454 Life Sciences, part of Roche (Basel, Switzerland), and researchers at Columbia University (New York) identified a virus associated with the deaths of 2.4 million honey bee colonies.
The findings explain how foreign organisms living in and among the bees were identified by reading sequences of DNA isolated from the bee colonies. The research identified five major bacterial groups, four lineages of fungi, and seven types of viruses. While most of the foreign organisms were found in both collapsed and healthy bee colonies, one virus, Israeli acute paralysis paralysis virus was found only in the collapsed colonies. Findings were reported in an online article of Science, according to a 454 Life Sciences press release.
“Unbiased 454 Sequencing technology enabled us to rapidly assemble a comprehensive inventory of microflora in Colony Collapse Disorder (CCD) and non-CCD populations, and provided the sequence information needed to identify candidate pathogens,” said Ian Lipkin, professor of epidemiology at Columbia University’s Mailman School of Public Health in a 454 Life Science release. “We view this work as a model for investigating epidemics of unexplained infectious disease.” Lipkin and his research team sequenced DNA and RNA samples that were extracted from collapsing and healthy bee colonies in search of any pathogen responsible for the collapse.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.